All Journals > The Journal of Infectious Diseases > 15 January 2008 > HBV Revaccination in HIV‐Infected Patients

Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

Science Watch logo

JID Article Named "New Hot Paper" by ScienceWatch.com

Dr. Lauri Hicks' 2007 article on pneumococcal disease has been named a "hot new paper" by Thompson Reuters' ScienceWatch.com. Read a Q&A about the article with Dr. Hicks here

Press Release

Unique Collaboration Charts the Migrations of a Parasite that Affected History
Researchers Sequence Louse DNA from Mummies and Propose New Model for its Development


In the News

Featured in Grist
"Another symptom of swine flu: instant amnesia" May 11, 2009
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Read the veterinary literature on swine flu and you get a strong sense of what might be called vaccination treadmill: the hog industry is literally scrambling to generate new vaccines for the rapidly evolving flu strains that sweep through CAFOs. Writing in the Journal of Infectious Diseases [PDF] in 2008, Eileen Thacker and Bruce Janke of Iowa State University paint a stark picture: “A number of genetically diverse viruses are circulating in swine herds throughout the world and are a major cause of concern to the swine industry,” they write. “Influenza virus infections in swine and poultry are potential sources of viruses for the next pandemic among humans.”

Featured in New York Times
"Fear of a Swine Flu Epidemic in 1976 Offers Some Lessons, and Concerns, Today" May 8, 2009
Anti‐Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine‐Associated Guillain‐Barré Syndrome
Irving Nachamkin, Sean V. Shadomy, Anthony P. Moran, Nancy Cox, Collette Fitzgerald, Huong Ung, Adrian T. Corcoran, John K. Iskander, Lawrence B. Schonberger, and Robert T. Chen
Irving Nachamkin, a professor of pathology and laboratory medicine at the University of Pennsylvania, examined some 1976 vaccine that had been saved by a scientist in Texas. In a paper published last year in The Journal of Infectious Diseases, he and colleagues reported that mice given the vaccine made antibodies that reacted with gangliosides, which are components of nerve cells. An antibody attack on gangliosides is part of the disease mechanism of Guillain-Barré.

Featured in AFP
"Swine flu vaccine 'could be ready soon'" May 7, 2009
A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses
Mary A. Hoelscher, Neetu Singh, Sanjay Garg, Lakshmi Jayashankar, Vic Veguilla, Aseem Pandey, Yumi Matsuoka, Jacqueline M. Katz, Ruben Donis, Suresh K. Mittal, and Suryaprakash Sambhara
The vaccine Mittal created for the bird flu worked on three different strains isolated over a seven-year period and was described in papers for the Journal of Infectious Diseases and the journal Clinical Pharmacology and Therapeutics.

Featured in Newsweek
"The Path of a Pandemic" http://www.newsweek.com/id/195692
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Last year researchers from Iowa State University in Ames warned that pigs located in industrial-scale farms were being subjected to influenza infections from farm poultry, wild birds and their human handlers. Writing in The Journal of Infectious Diseases, Eileen Thacker and Bruce Janke said, "As a result of the constantly changing genetic makeup of individual influenza viruses in pigs, the U.S. swine industry is continually scrambling to respond to the influenza viruses circulating within individual production systems."

15 January 2008

Volume 197, Number 2
The Journal of Infectious Diseases 2008;197:292–294
0022-1899/2008/19702-0018$15.00
DOI: 10.1086/524690
BRIEF REPORT

A Prospective Open Study of the Efficacy of High‐Dose Recombinant Hepatitis B Rechallenge Vaccination in HIV‐Infected Patients

Theodora E. M. S. de Vries‐Sluijs,1

Bettina E. Hansen,2,3

Gerard J. J. van Doornum,4

Tirza Springeling,1

Nicole M. Evertsz,1

Robert A. de Man,3 and

Marchina E. van der Ende1

Departments of 1Internal Medicine, Infectious Diseases Section, 2Epidemiology and Biostatistics, 3Gastroenterology and Hepatology, and 4Virology, Erasmus Medical Center, Rotterdam, The Netherlands

Double‐dose hepatitis B virus revaccination of human immunodeficiency virus (HIV)–infected patients proved to be effective in 50.7% of 144 patients who had previously failed to respond to standard doses. In the multivariate analysis, female patients were found to have a significantly better response ( ). The effect of age on the response depended on the viral load at the time of revaccination. For patients with a detectable HIV RNA load, the effect of age was stronger (odds ratio [OR], 0.34 per 10 years older [95% confidence interval {CI}, 0.16–0.72]; ) than for patients with an undetectable HIV RNA load (OR, 0.74 per 10 years older [95% CI, 0.50–1.09]; ).

Received 2 May 2007; accepted 26 July 2007; electronically published 4 January 2008.

Reprints or correspondence: Dr. Theodora E. M. S. de Vries‐Sluijs, Dept. of Internal Medicine, Infectious Diseases Section, Erasmus MC, University Medical Center Rotterdam, ’s‐Gravendijkwal 230, Rm. L‐319, 3015 CE Rotterdam, The Netherlands ().

Cited by

Mamta K. Jain. (2009) Editorial Commentary: Mortality in Patients Coinfected with Hepatitis B Virus and HIV: Could Antiretroviral Therapy Make a Difference?. Clinical Infectious Diseases 48:12, 1772-1774
Online publication date: 15-Jun-2009.
Allyson Bloom, Katherine Jackson, Aurora Kiviat, Hui Zheng, Paul Sax, Rajesh Gandhi. (2009) Repeat Hepatitis B Vaccination May Lead to Seroprotection in HIV-Infected Patients Who Do Not Respond to an Initial Series. JAIDS Journal of Acquired Immune Deficiency Syndromes 50:1, 110-113
Online publication date: 1-Feb-2009.
CrossRef
  • Potential conflicts of interest: none reported.

    Presented in part: 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles, 25–28 February 2007 (abstract 883).

    Financial support: Stichting Nuts Ohra (grant SNO‐T‐07‐102); Municipal Health Services, The Netherlands.

Close Popup